The facility’s sponsors used the country’s first green and social project bond to gather €288m for Elazig PPP.
Tag Archives | Asia Pacific
China remains the largest player in Asia for cross border deals, with $7.4bn in total deal value or 85% of the region in 1H 2016.
Bain Capital-owned Asia Pacific Medical Group has sold plastic surgery chain The Sloane Clinic to Singapore-listed China Medical International Group for $9.5 million.
The Singapore-based JV will initially focus on the healthcare sector in the Asia-Pacific region, including Japan and Australia.
The deal marks the firm’s sixth bolt-on acquisition from its second fund, ¥20.4bn J-STAR No 2 Investment Limited Partnership.
Reforms in Australia’s healthcare sector, a low dollar and the country’s ageing population continue to make the healthcare industry attractive for PE investors.
CVC’s investment in Hasegawa Holdings follows its $300m acquisition of South Korean parcel company Logen Group.
Generic injectable pharmaceutical products company Gland Pharma Limited has been acquired by Chinese healthcare provider Shanghai Fosun Pharmaceutical.
Having grown GenesisCare’s business in Europe through acquisitions and partnerships, KKR is selling its 45% stake in the healthcare provider to China Resources Group and Macquarie Capital.
Guangshao Tu, a known reformer who was previously asked to lead the entire organisation, has joined as vice-chairman.